Sergi Padilla-Parra

Dr. Sergi Padilla-Parra

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2016 in Nature
Verified
Journal Article
Open access
PDF file
Yuguang ZhaoYuguang Zhao
Yuguang Zhao
JRJingshan Ren
Jingshan Ren
KHKarl Harlos
Karl Harlos
DJDaniel M. Jones
Daniel M. Jones
AZAntra Zeltina
Antra Zeltina
DSDavid Ian Stuart
David Ian Stuart
High-resolution structures of the unliganded Ebola virus glycoprotein (GP) and of GP bound to the drugs toremifene and ibuprofen are presented, providing insights into how the drugs inhibit viral fusion with the endosomal membrane. David Stuart and colleagues provide the first unliganded structure of Ebola virus glycoprotein, which is the sole viral protein responsible for host cell attachment and membrane fusion, and is therefore a logical target for development of antiviral drugs. They also determine the structures of the glycoprotein in complex with two drugs previously shown to have an inhibitory effect on Ebola virus replication, toremifene and ibuprofen, providing insight into how these drugs inhibit viral fusion with the endosomal membrane. Ebola viruses (EBOVs) are responsible for repeated outbreaks of fatal infections, including the recent deadly epidemic in West Africa. There are currently no approved therapeutic drugs or vaccines for the disease. EBOV has a membrane envelope decorated by trimers of a glycoprotein (GP, cleaved by furin to form GP1 and GP2 subunits), which is solely responsible for host cell attachment, endosomal entry and membrane fusion1,2,3,4,5,6,7. GP is thus a primary target for the development of antiviral drugs. Here we report the first, to our knowledge, unliganded structure of EBOV GP, and high-resolution complexes of GP with the anticancer drug toremifene and the painkiller ibuprofen. The high-resolution apo structure gives a more complete and accurate picture of the molecule, and allows conformational changes introduced by antibody and receptor binding to be deciphered8,9,10. Unexpectedly, both toremifene and ibuprofen bind in a cavity between the attachment (GP1) and fusion (GP2) subunits at the entrance to a large tunnel that links with equivalent tunnels from the other monomers of the trimer at the three-fold axis. Protein–drug interactions with both GP1 and GP2 are predominately hydrophobic. Residues lining the binding site are highly conserved among filoviruses except Marburg virus (MARV), suggesting that MARV may not bind these drugs. Thermal shift assays show up to a 14 °C decrease in the protein melting temperature after toremifene binding, while ibuprofen has only a marginal effect and is a less potent inhibitor. These results suggest that inhibitor binding destabilizes GP and triggers premature release of GP2, thereby preventing fusion between the viral and endosome membranes. Thus, these complex structures reveal the mechanism of inhibition and may guide the development of more powerful anti-EBOV drugs.

13 March 2012 in BioEssays
Verified
Journal Article
Closed access
PDF file
SPSergi Padilla-Parra
Sergi Padilla-Parra
Marc TramierMarc Tramier
Marc Tramier

14 July 2014 in Nature Communications
Verified
Journal Article
Open access
YZYuguang Zhao
Yuguang Zhao
JRJingshan Ren
Jingshan Ren
SPSergi Padilla-Parra
Sergi Padilla-Parra
EFElizabeth Fry
Elizabeth Fry
DSDavid Ian Stuart
David Ian Stuart
The integral membrane protein LIMP-2 has been a paradigm for mannose 6-phosphate receptor (MPR) independent lysosomal targeting, binding to β-glucocerebrosidase (β-GCase) and directing it to the lysosome, before dissociating in the late-endosomal/lysosomal compartments. Here we report structural results illuminating how LIMP-2 binds and releases β-GCase according to changes in pH, via a histidine trigger, and suggesting that LIMP-2 localizes the ceramide portion of the substrate adjacent to the β-GCase catalytic site. Remarkably, we find that LIMP-2 bears P-Man9GlcNAc2 covalently attached to residue N325, and that it binds MPR, via mannose 6-phosphate, with a similar affinity to that observed between LIMP-2 and β-GCase. The binding sites for β-GCase and the MPR are functionally separate, so that a stable ternary complex can be formed. By fluorescence lifetime imaging microscopy, we also demonstrate that LIMP-2 interacts with MPR in living cells. These results revise the accepted view of LIMP-2–β-GCase lysosomal targeting.

4 February 2019 in Nature Immunology
Verified
Journal Article
Open access
PDF file
CAConsuelo Anzilotti
Consuelo Anzilotti
DSDavid J. Swan
David J. Swan
BBBertrand Boisson
Bertrand Boisson
MDMukta Deobagkar-Lele
Mukta Deobagkar-Lele
COCatarina Oliveira
Catarina Oliveira
SHSophie Hambleton
Sophie Hambleton
Despite the known importance of zinc for human immunity, molecular insights into its roles have remained limited. Here we report a novel autosomal recessive disease characterized by absent B cells, agammaglobulinemia and early onset infections in five unrelated families. The immunodeficiency results from hypomorphic mutations of SLC39A7, which encodes the endoplasmic reticulum-to-cytoplasm zinc transporter ZIP7. Using CRISPR-Cas9 mutagenesis we have precisely modeled ZIP7 deficiency in mice. Homozygosity for a null allele caused embryonic death, but hypomorphic alleles reproduced the block in B cell development seen in patients. B cells from mutant mice exhibited a diminished concentration of cytoplasmic free zinc, increased phosphatase activity and decreased phosphorylation of signaling molecules downstream of the pre-B cell and B cell receptors. Our findings highlight a specific role for cytosolic Zn2+ in modulating B cell receptor signal strength and positive selection.

1 August 2016 in Neuron
Verified
Journal Article
Open access
YKYouxin Kong
Youxin Kong
BJBert J.C. Janssen
Bert J.C. Janssen
TMTomas Malinauskas
Tomas Malinauskas
VVVamshidhar R. Vangoor
Vamshidhar R. Vangoor
CCCharlotte H. Coles
Charlotte H. Coles
EJE. Yvonne Jones
E. Yvonne Jones
Class A plexins (PlxnAs) act as semaphorin receptors and control diverse aspects of nervous system development and plasticity, ranging from axon guidance and neuron migration to synaptic organization. PlxnA signaling requires cytoplasmic domain dimerization, but extracellular regulation and activation mechanisms remain unclear. Here we present crystal structures of PlxnA (PlxnA1, PlxnA2, and PlxnA4) full ectodomains. Domains 1-9 form a ring-like conformation from which the C-terminal domain 10 points away. All our PlxnA ectodomain structures show autoinhibitory, intermolecular "head-to-stalk" (domain 1 to domain 4-5) interactions, which are confirmed by biophysical assays, live cell fluorescence microscopy, and cell-based and neuronal growth cone collapse assays. This work reveals a 2-fold role of the PlxnA ectodomains: imposing a pre-signaling autoinhibitory separation for the cytoplasmic domains via intermolecular head-to-stalk interactions and supporting dimerization-based PlxnA activation upon ligand binding. More generally, our data identify a novel molecular mechanism for preventing premature activation of axon guidance receptors.

4 May 2015 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
EHEleanor G Healey
Eleanor G Healey
BBBenjamin Bishop
Benjamin Bishop
JEJonathan Elegheert
Jonathan Elegheert
CBChristian H Bell
Christian H Bell
SPSergi Padilla-Parra
Sergi Padilla-Parra
CSChristian Siebold
Christian Siebold
Structural and functional analyses reveal how human repulsive-guidance-molecule glycoproteins activate bone morphogenic protein (BMP) signaling and physically link the latter to the neogenin pathway. Repulsive guidance molecules (RGMs) control crucial processes including cell motility, adhesion, immune-cell regulation and systemic iron metabolism. RGMs signal via the neogenin (NEO1) and the bone morphogenetic protein (BMP) pathways. Here, we report crystal structures of the N-terminal domains of all human RGM family members in complex with the BMP ligand BMP2, revealing a new protein fold and a conserved BMP-binding mode. Our structural and functional data suggest a pH-linked mechanism for RGM-activated BMP signaling and offer a rationale for RGM mutations causing juvenile hemochromatosis. We also determined the crystal structure of the ternary BMP2–RGM–NEO1 complex, which, along with solution scattering and live-cell super-resolution fluorescence microscopy, indicates BMP-induced clustering of the RGM–NEO1 complex. Our results show how RGM acts as the central hub that links BMP and NEO1 and physically connects these fundamental signaling pathways.